218 related articles for article (PubMed ID: 29971221)
1. Colony and Single Cell Level Analysis of the Heterogeneous Response of
Altamirano S; Simmons C; Kozubowski L
Front Cell Infect Microbiol; 2018; 8():203. PubMed ID: 29971221
[No Abstract] [Full Text] [Related]
2. Cryptococcus neoformans, Unlike Candida albicans, Forms Aneuploid Clones Directly from Uninucleated Cells under Fluconazole Stress.
Chang YC; Khanal Lamichhane A; Kwon-Chung KJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514783
[TBL] [Abstract][Full Text] [Related]
3. Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.
Sionov E; Chang YC; Garraffo HM; Kwon-Chung KJ
Antimicrob Agents Chemother; 2009 Jul; 53(7):2804-15. PubMed ID: 19414582
[TBL] [Abstract][Full Text] [Related]
4. Fluconazole induces ROS in Cryptococcus neoformans and contributes to DNA damage in vitro.
Peng CA; Gaertner AAE; Henriquez SA; Fang D; Colon-Reyes RJ; Brumaghim JL; Kozubowski L
PLoS One; 2018; 13(12):e0208471. PubMed ID: 30532246
[TBL] [Abstract][Full Text] [Related]
5. Investigation of fluconazole heteroresistance in clinical and environmental isolates of Cryptococcus neoformans complex and Cryptococcus gattii complex in the state of Amazonas, Brazil.
Moreira IMB; Cortez ACA; de Souza ÉS; Pinheiro SB; de Souza Oliveira JG; Sadahiro A; Cruz KS; Matsuura ABJ; Melhem MSC; Frickmann H; de Souza JVB
Med Mycol; 2022 Mar; 60(3):. PubMed ID: 35084497
[TBL] [Abstract][Full Text] [Related]
6. Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B.
Carlson T; Lupinacci E; Moseley K; Chandrasekaran S
FEMS Microbiol Lett; 2021 May; 368(7):. PubMed ID: 33877319
[TBL] [Abstract][Full Text] [Related]
7. Coregulation of extracellular vesicle production and fluconazole susceptibility in
Rizzo J; Trottier A; Moyrand F; Coppée JY; Maufrais C; Zimbres ACG; Dang TTV; Alanio A; Desnos-Ollivier M; Mouyna I; Péhau-Arnaude G; Commere PH; Novault S; Ene IV; Nimrichter L; Rodrigues ML; Janbon G
mBio; 2023 Aug; 14(4):e0087023. PubMed ID: 37310732
[TBL] [Abstract][Full Text] [Related]
8. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes.
Sionov E; Lee H; Chang YC; Kwon-Chung KJ
PLoS Pathog; 2010 Apr; 6(4):e1000848. PubMed ID: 20368972
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
Sionov E; Chang YC; Garraffo HM; Dolan MA; Ghannoum MA; Kwon-Chung KJ
Antimicrob Agents Chemother; 2012 Mar; 56(3):1162-9. PubMed ID: 22155829
[TBL] [Abstract][Full Text] [Related]
10. Increase of reactive oxygen species contributes to growth inhibition by fluconazole in Cryptococcus neoformans.
Dbouk NH; Covington MB; Nguyen K; Chandrasekaran S
BMC Microbiol; 2019 Nov; 19(1):243. PubMed ID: 31694529
[TBL] [Abstract][Full Text] [Related]
11. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G
Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
[TBL] [Abstract][Full Text] [Related]
12. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex.
Cordeiro RA; Evangelista AJJ; Serpa R; Marques FJF; Melo CVS; Oliveira JS; Franco JDS; Alencar LP; Bandeira TJPG; Brilhante RSN; Sidrim JJC; Rocha MFG
Microbiology (Reading); 2016 Feb; 162(2):309-317. PubMed ID: 26645478
[TBL] [Abstract][Full Text] [Related]
14. Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans.
Huang W; Liao G; Baker GM; Wang Y; Lau R; Paderu P; Perlin DS; Xue C
mBio; 2016 May; 7(3):. PubMed ID: 27165800
[TBL] [Abstract][Full Text] [Related]
15. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii.
Vu K; Gelli A
Med Mycol; 2010 Mar; 48(2):255-62. PubMed ID: 19572230
[TBL] [Abstract][Full Text] [Related]
16. Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.
Nielsen K; Vedula P; Smith KD; Meya DB; Garvey EP; Hoekstra WJ; Schotzinger RJ; Boulware DR
Med Mycol; 2017 Jun; 55(4):453-456. PubMed ID: 27664991
[TBL] [Abstract][Full Text] [Related]
17. Environmental Triazole Induces Cross-Resistance to Clinical Drugs and Affects Morphophysiology and Virulence of Cryptococcus gattii and C. neoformans.
Bastos RW; Carneiro HCS; Oliveira LVN; Rocha KM; Freitas GJC; Costa MC; Magalhães TFF; Carvalho VSD; Rocha CE; Ferreira GF; Paixão TA; Moyrand F; Janbon G; Santos DA
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109169
[No Abstract] [Full Text] [Related]
18. Characterization of heteroresistance to fluconazole among clinical isolates of Cryptococcus neoformans.
Yamazumi T; Pfaller MA; Messer SA; Houston AK; Boyken L; Hollis RJ; Furuta I; Jones RN
J Clin Microbiol; 2003 Jan; 41(1):267-72. PubMed ID: 12517859
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcus neoformans Yop1 , an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation.
Ngamskulrungroj P; Chang Y; Hansen B; Bugge C; Fischer E; Kwon-Chung KJ
FEMS Yeast Res; 2012 Nov; 12(7):748-54. PubMed ID: 22731401
[TBL] [Abstract][Full Text] [Related]
20. Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis.
Stone NR; Rhodes J; Fisher MC; Mfinanga S; Kivuyo S; Rugemalila J; Segal ES; Needleman L; Molloy SF; Kwon-Chung J; Harrison TS; Hope W; Berman J; Bicanic T
J Clin Invest; 2019 Mar; 129(3):999-1014. PubMed ID: 30688656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
